Tagged with oncology,

Turkey Ece Kaşıkçı, General Manager, Bristol-Myers Squibb (BMS) Turkey, outlines how BMS’ groundbreaking immuno-oncology therapy has proudly become the first product of its kind to be registered and reimbursed in the country. She also highlights the company’s collaborative approach to reach this remarkable milestone. Ece also discusses her vision for BMS…

Algeria Professor Kamel Bouzid, president of the Algerian Society of Medical Oncology, provides an insight into the efforts to fight against cancer in Algeria. Could you please give us an overview of the cancer prevalence in Algeria? In Algeria, 75 percent of cancers are metastasized cancers, and only 25 percent are…

Algeria Prof. Messaoud Zitouni, head of the Algerian National Cancer Plan, highlights the Plan’s main advancements since 2015 as well as the gaps to still address. Three years after the launch of the Cancer Plan, what is the current status on achievements? Initially laid out as a five-year plan, two now…

Turkey In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent. Treve provided insights into the main opportunities and challenges of the Turkish market, Roche’s unrivalled commitment to making a difference…

Spain Josep Taberno MD PhD, director of VHIO, introduces the important work being conducted by the cancer institute in Spain as well as emerging trends in oncology. Can you tell us about VHIO? “ The complexities in cancer treatment and care are myriad. That said, I firmly believe that we can…

Turkey Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the healthcare sector. However, he has high hopes that the country will continue to prioritize oncology as a key therapeutic area…

Spain The managing director of the Spanish affiliate of one of France’s most exciting and ambitious mid-caps speaks out about crafting a commercial powerhouse and efficient launch machine in oncology, and shares the secrets of deftly managing organizational change.    How would you describe Ipsen´s legacy and footprint within the Spanish…

UK Having recently been able to present positive data for their lead technology IMCgp100 in uveal melanoma at the American Society of Clinical Oncology (ASCO), Immunocore looks at its future as a homegrown British biotech with confidence. Its CEO Andrew Hotchkiss also shares some of the up-coming investigation programmes for Immunocore’s…

Baltics Rauls Velins, Roche’s general manager for Latvia, introduces the company’s longstanding commitment to the Latvian market, Roche’s role in helping facilitate Latvia’s new National Cancer Plan, and the potential for personalized medicine across the Baltics. Could you please start by introducing Roche in Latvia and the strategic significance of the…

Ecuador Antonio Carlos Matos da Silva, general manager of Roche Ecuador explains how his ability to manage by influence has helped him transition smoothly into his first GM position. The Brazilian manager has great ambitions for the Ecuadorian affiliate of the oncology global giant, elaborating on Vision 2020; a plan he…

Canada Taiho Pharmaceutical Co., Ltd. (TPC), Japan, part of Otsuka Holdings, established its Canadian affiliate in 2017. Ross Glover, general manager for Taiho Pharma Canada, has spent the past year tackling the mammoth task of establishing the foundations for the operations, including preparing a new drug for market approval and navigating…

Poland Joanna Drewla, general manager of Servier Poland, discusses Polish healthcare challenges and looks at areas for improvement to create a sustainable balance for market access of innovative treatments. Furthermore, she highlights the strategic importance of Servier in Poland, with the International Center for CEE clinical research and the company’s fifth…